Codiak Biosciences

Codiak Biosciences

The leader in the emerging field of exosome therapeutics, working to harness the power of this cellular messenger system to create potentially life-changing medicines.

HQ location
San Francisco, United States
Website
codiakbio.com
Launch date
Employees
51-200 people
Market cap
$877k
Enterprise value
$10m
Share price
$0.06 CDAK
https://twitter.com/codiakbiohttps://www.linkedin.com/company/codiak-biosciences/
    • Edit
loading funding rounds…
Alaska Permanent Fund
Alaska Permanent Fund(exited)
ARCH Venture Partners
ARCH Venture Partners(exited)
Flagship Pioneering
Flagship Pioneering(exited)
Yukon Partners
Yukon Partners(exited)
Alexandria Venture Investments
Alexandria Venture Investments(exited)
Boxer Capital
Boxer Capital(exited)
Casdin Capital
Casdin Capital(exited)
EcoR1 Capital
EcoR1 Capital(exited)
Qatar Investment Authority
Qatar Investment Authority(exited)
Sirona Capital
Sirona Capital(exited)
Evox Therapeutics
Evox Therapeutics

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo